Skip to main content
Top
Published in: Acta Neurologica Belgica 2/2021

Open Access 01-04-2021 | Stroke | Original article

Predictors of mortality and disability in stroke-associated pneumonia

Authors: Rory J. Tinker, Craig J. Smith, Calvin Heal, Joao H. Bettencourt-Silva, Anthony K. Metcalf, John F. Potter, Phyo K. Myint

Published in: Acta Neurologica Belgica | Issue 2/2021

Login to get access

Abstract

Whilst stroke-associated pneumonia (SAP) is common and associated with poor outcomes, less is known about the determinants of these adverse clinical outcomes in SAP. To identify the factors that influence mortality and morbidity in SAP. Data for patients with SAP (n = 854) were extracted from a regional Hospital Stroke Register in Norfolk, UK (2003–2015). SAP was defined as pneumonia occurring within 7 days of admission by the treating clinicians. Mutlivariable regression models were constructed to assess factors influencing survival and the level of disability at discharge using modified Rankin Scale [mRS]. Mean (SD) age was 83.0 (8.7) years and ischaemic stroke occurred in 727 (85.0%). Mortality was 19.0% at 30 days and 44.0% at 6 months. Stroke severity assessment using National Institutes of Health Stroke Scale was not recorded in the data set although Oxfordshire Community Stroke Project was Classification. In the multivariable analyses, 30-day mortality was independently associated with age (OR 1.04, 95% CI 1.01–1.07, p = 0.01), haemorrhagic stroke (2.27, 1.07–4.78, p = 0.03) and pre-stroke disability (mRS 4–5 v 0–1: 6.45, 3.12–13.35, p < 0.001). 6-month mortality was independently associated with age (< 0.001), pre-stroke disability (p < 0.001) and certain comorbidities, including the following: dementia (6.53, 4.73–9.03, p < 0.001), lung cancer (2.07, 1.14–3.77, p = 0.017) and previous transient ischemic attack (1.94, 1.12–3.36, p = 0.019). Disability defined by mRS at discharge was independently associated with age (1.10, 1.05–1.16, p < 0.001) and plasma C-reactive protein (1.02, 1.01–1.03, p = 0.012). We have identified non-modifiable determinants of poor prognosis in patients with SAP. Further studies are required to identify modifiable factors which may guide areas for intervention to improve the prognosis in SAP in these patients.
Appendix
Available only for authorised users
Literature
1.
go back to reference Feigin VL, Norrving B, Mensah GA (2017) Global burden of stroke. Circ Res 120(3):439CrossRef Feigin VL, Norrving B, Mensah GA (2017) Global burden of stroke. Circ Res 120(3):439CrossRef
2.
go back to reference Di Carlo A (2009) Human and economic burden of stroke. Age Ageing 38(1):4–5CrossRef Di Carlo A (2009) Human and economic burden of stroke. Age Ageing 38(1):4–5CrossRef
3.
go back to reference Armstrong JR, Mosher BD (2011) Aspiration pneumonia after stroke: intervention and prevention. Neurohospitalist 1(2):85–93CrossRef Armstrong JR, Mosher BD (2011) Aspiration pneumonia after stroke: intervention and prevention. Neurohospitalist 1(2):85–93CrossRef
4.
go back to reference Hannawi Y, Hannawi B, Rao CP et al (2013) Stroke-associated pneumonia: major advances and obstacles. Cerebrovasc Dis 35(5):430–443CrossRef Hannawi Y, Hannawi B, Rao CP et al (2013) Stroke-associated pneumonia: major advances and obstacles. Cerebrovasc Dis 35(5):430–443CrossRef
5.
go back to reference Kishore AK, Vail A, Chamorro A et al (2015) How is pneumonia diagnosed in clinical stroke research? A systematic review and meta-analysis. Stroke 46(5):1202–1209CrossRef Kishore AK, Vail A, Chamorro A et al (2015) How is pneumonia diagnosed in clinical stroke research? A systematic review and meta-analysis. Stroke 46(5):1202–1209CrossRef
6.
go back to reference Ali AN, Howe J, Majid A et al (2018) The economic cost of stroke-associated pneumonia in a UK setting. Top Stroke Rehabil 25(3):214–223CrossRef Ali AN, Howe J, Majid A et al (2018) The economic cost of stroke-associated pneumonia in a UK setting. Top Stroke Rehabil 25(3):214–223CrossRef
7.
go back to reference Kishore AK, Vail A, Benjamin DB et al (2016) Clinical risk scores for predicting stroke-associated pneumonia: a systematic review. Eur Stroke J 1(2):76–84CrossRef Kishore AK, Vail A, Benjamin DB et al (2016) Clinical risk scores for predicting stroke-associated pneumonia: a systematic review. Eur Stroke J 1(2):76–84CrossRef
8.
go back to reference Liu J-L, Feng XA, Zhou H et al (2016) Expanded CURB-65: a new score system predicts severity of community-acquired pneumonia with superior efficiency. Sci Rep 6:22911CrossRef Liu J-L, Feng XA, Zhou H et al (2016) Expanded CURB-65: a new score system predicts severity of community-acquired pneumonia with superior efficiency. Sci Rep 6:22911CrossRef
9.
go back to reference Marti C et al (2012) Prediction of severe community-acquired pneumonia: a systematic review and meta-analysis. Crit Care 16(4):R141CrossRef Marti C et al (2012) Prediction of severe community-acquired pneumonia: a systematic review and meta-analysis. Crit Care 16(4):R141CrossRef
10.
go back to reference Barlas RS et al (2018) Effect of antiplatelet therapy (aspirin+dipyridamole versus clopidogrel) on mortality outcome in ischemic stroke. Am J Cardiol 122(6):1085–1090CrossRef Barlas RS et al (2018) Effect of antiplatelet therapy (aspirin+dipyridamole versus clopidogrel) on mortality outcome in ischemic stroke. Am J Cardiol 122(6):1085–1090CrossRef
11.
go back to reference Sharma K, Johnson JJ, Johnson B et al (2018) Hemoglobin concentration does not impact 3-month outcome following acute ischemic stroke. BMC Neurol 18:78CrossRef Sharma K, Johnson JJ, Johnson B et al (2018) Hemoglobin concentration does not impact 3-month outcome following acute ischemic stroke. BMC Neurol 18:78CrossRef
12.
go back to reference Lim WS, Baudouin SV, George RC et al (2009) BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 64:iii1–iii55CrossRef Lim WS, Baudouin SV, George RC et al (2009) BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 64:iii1–iii55CrossRef
13.
go back to reference Teh WH et al (2018) Impact of stroke-associated pneumonia on mortality, length of hospitalization, and functional outcome. Acta Neurol Scand 138(4):293–300CrossRef Teh WH et al (2018) Impact of stroke-associated pneumonia on mortality, length of hospitalization, and functional outcome. Acta Neurol Scand 138(4):293–300CrossRef
14.
go back to reference Smith CJ et al (2015) Diagnosis of stroke-associated pneumonia: recommendations from the pneumonia in stroke consensus group. Stroke 46(8):2335–2340CrossRef Smith CJ et al (2015) Diagnosis of stroke-associated pneumonia: recommendations from the pneumonia in stroke consensus group. Stroke 46(8):2335–2340CrossRef
15.
go back to reference Mortensen E, Kapoor WN, Chung-Chou H et al (2003) Assessment of mortality after long-term follow-up of patients with community-acquired pneumonia. Clin Infect Dis 37(12):1617–1624CrossRef Mortensen E, Kapoor WN, Chung-Chou H et al (2003) Assessment of mortality after long-term follow-up of patients with community-acquired pneumonia. Clin Infect Dis 37(12):1617–1624CrossRef
16.
go back to reference Restrepo MI, Faverio P, Anzueto A (2013) Long-term prognosis in community-acquired pneumonia. Curr Opin Infect Dis 26(2):151–158CrossRef Restrepo MI, Faverio P, Anzueto A (2013) Long-term prognosis in community-acquired pneumonia. Curr Opin Infect Dis 26(2):151–158CrossRef
17.
go back to reference Metersky ML, Waterer G, Nsa W et al (2012) Predictors of in-hospital vs postdischarge mortality in pneumonia. Chest 142(2):476–481CrossRef Metersky ML, Waterer G, Nsa W et al (2012) Predictors of in-hospital vs postdischarge mortality in pneumonia. Chest 142(2):476–481CrossRef
18.
go back to reference Carmo J, Morelato RL, Pinto HP et al (2015) Disability after stroke: a systematic review. Fisioterapia Em Movimento 28:407–418CrossRef Carmo J, Morelato RL, Pinto HP et al (2015) Disability after stroke: a systematic review. Fisioterapia Em Movimento 28:407–418CrossRef
19.
go back to reference Brønnum-Hansen H, Davidsen M, Thorvaldsen P et al (2001) Long-term survival and causes of death after stroke. Stroke 32(9):2131CrossRef Brønnum-Hansen H, Davidsen M, Thorvaldsen P et al (2001) Long-term survival and causes of death after stroke. Stroke 32(9):2131CrossRef
20.
go back to reference Boysen G, Marott J, Gronbaek M et al (2009) Long-term survival after stroke: 30 years of follow-up in a cohort, the copenhagen city heart study. Neuroepidemiology 33(3):254–260CrossRef Boysen G, Marott J, Gronbaek M et al (2009) Long-term survival after stroke: 30 years of follow-up in a cohort, the copenhagen city heart study. Neuroepidemiology 33(3):254–260CrossRef
21.
go back to reference Koton S, Tanne D, Green MS et al (2010) Mortality and predictors of death 1 month and 3 years after first-ever ischemic stroke: data from the first national acute stroke Israeli survey (NASIS 2004). Neuroepidemiology 34(2):90–96CrossRef Koton S, Tanne D, Green MS et al (2010) Mortality and predictors of death 1 month and 3 years after first-ever ischemic stroke: data from the first national acute stroke Israeli survey (NASIS 2004). Neuroepidemiology 34(2):90–96CrossRef
22.
go back to reference Anrather J, Iadecola C (2016) Inflammation and stroke: an overview. Neurotherapeutics 13(4):661–670CrossRef Anrather J, Iadecola C (2016) Inflammation and stroke: an overview. Neurotherapeutics 13(4):661–670CrossRef
23.
go back to reference Dziedzic T (2015) Systemic inflammation as a therapeutic target in acute ischemic stroke. Expert Rev Neurother 15(5):523–531CrossRef Dziedzic T (2015) Systemic inflammation as a therapeutic target in acute ischemic stroke. Expert Rev Neurother 15(5):523–531CrossRef
24.
go back to reference Thiem U, Niklaus D, Sehlhoff B et al (2009) C-reactive protein, severity of pneumonia and mortality in elderly, hospitalised patients with community-acquired pneumonia. Age Ageing 38(6):693–697CrossRef Thiem U, Niklaus D, Sehlhoff B et al (2009) C-reactive protein, severity of pneumonia and mortality in elderly, hospitalised patients with community-acquired pneumonia. Age Ageing 38(6):693–697CrossRef
Metadata
Title
Predictors of mortality and disability in stroke-associated pneumonia
Authors
Rory J. Tinker
Craig J. Smith
Calvin Heal
Joao H. Bettencourt-Silva
Anthony K. Metcalf
John F. Potter
Phyo K. Myint
Publication date
01-04-2021
Publisher
Springer International Publishing
Published in
Acta Neurologica Belgica / Issue 2/2021
Print ISSN: 0300-9009
Electronic ISSN: 2240-2993
DOI
https://doi.org/10.1007/s13760-019-01148-w

Other articles of this Issue 2/2021

Acta Neurologica Belgica 2/2021 Go to the issue